Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The role of prolactin and growth hormone in breast cancer

Abstract

This review will focus on the role for prolactin (PRL) and growth hormone (GH) in mammary tumor formation. Much attention has previously been focused on circulating levels of GH/PRL in relation to mammary tumor formation. We will review data demonstrating that these ligands also could be produced locally in different organs, including the mammary gland and mammary tumors, and suggest that this local production may be of importance for pathological conditions. We will also discuss mechanisms for crosstalk between steroids and GH/PRL. A crosstalk between GH- and PRL response is possible at multiple levels. In the human, GH can activate both the prolactin receptor (PRLR) and the growth hormone receptor (GHR). We have demonstrated that activation of the PRLR, but not the GHR, is inducing mammary tumors in transgenic mice. Furthermore, the elevated levels of insulin-like growth factor 1 (IGF-I) seen in the GHR activating transgenic mice is not sufficient for tumor induction. The induced tumors express functionally active prolactin that could be of importance for the tumor formation. Paracrine/aurocrine stimulation by PRL may be more important than PRL transported via the circulation. In women, the role for stimulation of the PRLR and/or the GHR in mammary tumor formation has not been proven, although experiments from primates suggest that the PRLR could be of importance.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  • Adler RA . 1986 Endocr. Rev. 7: 302–313.

  • Ben-Jonathan N, Mershon JL, Allen DL and Steinmetz RW. . 1996 Endocrine Rew. 17: 639–669.

  • Bonneterre J, Peyrat JP, Beuscart J, Lefebvre J and Demaille A. . 1987 Cancer Res. 47: 4724–4728.

  • Boutin J-M, Jolicoeur C, Okamura H, Gagnon J, Edery M, Shirota M, Banville D, Dusanter.Fourt I, Dijane J and Kelly PA. . 1988 Cell. 53: 69–77.

  • Burrow GN, Wortzman G, Rewcastle NB, Holgate RC and Kovacs K. . 1981 New Engl. J. Med. 304: 156–158.

  • Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT and Tomaszewski JE. . 1995 Am. J. Pathol. 146:: 695–705.

  • DaSilva L, Rui H, Erwin RA, Howard OM, Kirken RA, Malabarba MG, Hackett RH, Larner AC and Farrar WL. . 1996 Mol. Cell. Endocrinol. 117: 131–140.

  • Decouvelaere C, Peyrat JP, Bonneterre J, Dijane J and Jammes H. . 1995 Cell Growth and Differ. 6: 477–483.

  • Emerman JT, Leahy M, Gout PW and Bruchovsky N. . 1985 Horm. Metab. Res. 17: 421–424.

  • Feldman M, Ruan E, Cunningham BC, Wells JA and Kleinberg DL. . 1993 Endocrinology 133: 1602–1607.

  • Fuh G and Wells JA. . 1995 J. Biol. Chem. 270: 13133–13137.

  • Ginsburg E, Das R and Vonderhaar BK. . 1996 Biological Signaling and the Mammary Gland. Wilde CJ, Peaker M and Taylor E (eds). Hannah Symposium.

  • Ginsburg E and Vonderhaar BK. . 1995 Cancer Res. 55: 2591–2595.

  • Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z and Wood WI. . 1989 Proc. Natl. Acad. Sci. USA 86: 8083–8087.

  • Goffin V, Shiverick KT, Kelly PA and Martial JA. . 1996 Endocrine Rev. 17: 385–410.

  • Holtkamp W, Nagel GA, Wander HE, Rauschecker HF and von Heyden D. . 1984 Int. J. Cancer 34: 323–328.

  • Humphreys RC, Lydon J, O’Malley BW and Rosen JM. . 1997 Mol. Endocrinol. 11: 801–811.

  • Huseby RA, Soares MJ and Talamantes F. . 1985 Endocrinology 116: 1440–1448.

  • Ituarte EM, Pertini J and Hershman M. . 1984 Ann. Intern. Med. 101: 627–628.

  • Jahn GA, Edery M, Belair L, Kelly PA and Dijane J. . 1991 Endocrinology 128: 2976–2984.

  • Kleinberg DL, Ruan W, Catenese V, Newman CB and Feldman M. . 1990 Endocrinology 126: 3274–3276.

  • Kurtz A, Bristol LA, Tóth BE, Lazar-Wesley E, Takács L and Kacsóh B. . 1993 Biol. Reprod. 48: 1095–1103.

  • Kwa HG, De Jong Bakker M, Engelsman E and Cleton FJ. . 1974 Lancet 1: 433–435.

  • Leung DD, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ and Wood WI. . 1987 Nature 330: 1782–1788.

  • Liu X, Robinson GW and Hennighausen L. . 1996 Mol. Endocrinol. 10: 1496–1506.

  • Liu X, Robinson GW, Wagner K-U, Garrett L, Wynshaw-Boris A and Hennighausen L. . 1997 Genes Dev. 11: 179–186.

  • Matsuzawa A. . 1986 International Review of Cytology. Bourne GH and Jeon KW (eds).. Academic Press, New York. pp.103:303–341.

    Google Scholar 

  • Medina D. . 1982 The Mouse in Biomedical Research VolIV. Foster HL, Small JD and Fox JG. (eds).. Academic Press, New York. pp.373–396.

    Google Scholar 

  • Mershon J, Sall W, Mitcher N and Ben-Jonathan N. . 1995 Endocrinology 136:: 3619–3623.

  • Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, Vonderhaar BK, Waters MJ, Lobie PE and Morel G. . 1998 Interntl. J. Cancer 79: 202–211.

  • Mol JA, Henzen-Logmanns SC, Hageman P, Misdorp W, Blankenstein MA and Rijnberk A. . 1995 J. Clin. Endo. Metab. 80: 3094–3096.

  • Mol JA, van Garderen E, Selman PJ, Wolfswinkel J, Rijnberk A and Rutteman GR. . 1995 J. Clin. Invest. 95: 2028–2034.

  • Murphy JL, Murphy LC, Vrhovesek E, Sutherland RL and Lazarus L. . 1984 Cancer Res. 44: 1963–1968.

  • Musey VC, Collins DC, Musey PI, Martino-Saltzman D and Preedy JR. . 1987 N. Engl. J. Med. 316: 229–234.

  • Nabarro JD. . 1987 Clin. Endocrinol. 26: 327–335.

  • Nagasawa H. . 1979 Eur. J. Cancer 15: 267–279.

  • Ng ST, Zhou J, Adesanya OO, Wang J, leRoith D and Bondy CA. . 1997 Nature Med. 3: 1141–1144.

  • Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N and Kelly PA. . 1997 Gene Dev. 11: 167–178.

  • Reynolds C, Montone KT, Powell CM, Tomaszewski JE and Clevenger CV. . 1997 Endocrinology 138: 5555–5560.

  • Richter JK, Lange CA, Manning NG, Owen G, Powell R and Horwith KB. . 1998 J. Biol. Chem. 273: 31317–31326.

  • Ruan W, Catanese V, Wieczorek R, Feldman M and Kleinberg DL. . 1995 Endocrinology 136: 1296–1302.

  • Schmitt-Ney M, Happ B, Hofer P, Hynes NE and Groner B. . 1992 Mol. Endocrinol. 6: 1988–1997.

  • Selman PJ, Mol JA, Rutteman GR, van Garderen E and Rijnberk A. . 1994 Endocrinology 134: 287–292.

  • Silberstein GB, Van Horn K, Shyamala G and Daniel CW. . 1994 Endocrinology 134: 84–90.

  • Steinmetz RW, Grant AL and Malven PV. . 1993 J. Endocrinol. 36: 271–276.

  • Stocklin E, Wissler M, Gouilleux F and Groner B. . 1996 Nature 383: 726–728.

  • Topper YJ and Freeman CS. . 1980 Physiol. Rev. 60: 1049–1106.

  • Törnell J, Carlsson B, Pohjanen P, Wennbo H, Rymo L and Isaksson O. . 1992 J. Steroid Biochem. Mol. Biol. 43: 237–242.

  • Törnell J, Rymo L and Isaksson OGP. . 1991 Int. J. Cancer 49: 114–117.

  • Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ and Davey HW. . 1997 Proc. Natl. Acad. Sci. USA 94: 7239–7244.

  • VanGilder JC and Goldenberg IS. . 1975 Arch. Surg. 110: 293–295.

  • Wakao H, Gouilleux F and Groner B. . 1994 EMBO J. 13: 2182–2191.

  • Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG and Tornell J. . 1997 J. Clin. Invest. 100: 2744–2751.

  • Wood TJ, Sliva D, Lobie PE, Pircher TJ, Gouilleux F, Wakao H, Gustafsson JA, Groner B, Norstedt G and Haldosen LA. . 1995 J. Biol. Chem. 270: 9448–9453.

  • Yang XF, Beamer WG, Huynh H and Pollak M. . 1996 Cancer Res. 56: 1509–1511.

  • Zumoff B. . 1988 Anticancer Res. 8: 627–636.

Download references

Acknowledgements

This study was supported by the Swedish Cancer Foundation, Assar Gabrielsson's Cancer Foundation and the Swedish Medical Research Council.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wennbo, H., Törnell, J. The role of prolactin and growth hormone in breast cancer. Oncogene 19, 1072–1076 (2000). https://doi.org/10.1038/sj.onc.1203349

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203349

Keywords

This article is cited by

Search

Quick links